Calendar Immuneering Corporation

Equities

IMRX

US45254E1073

Market Closed - Nasdaq 04:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
1.5 USD -7.98% Intraday chart for Immuneering Corporation -18.48% -79.59%

Chart calendar Immuneering Corporation

2d0cd1edc7cefc363c0cb91.1qkRV_BjnBmMkxU2hRtbHwA18WezUnlcSFrWdixvIVg.r9h4MJIz-kzY60FMwzYeQGNbxjj_ID5qJwPlMEEEQA6anyBhlTKreNnrcg~ea8e094a8df5039b08ef16fed163f0d0

Upcoming events on Immuneering Corporation

2024-05-06 Q1 2024 Earnings Release (Projected)
2024-08-06 Q2 2024 Earnings Release (Projected)
2024-11-06 Q3 2024 Earnings Release (Projected)
2025-03-04 Q4 2024 Earnings Release (Projected)

Past events on Immuneering Corporation

2024-04-11 03:00 pm Needham Healthcare Conference
2024-04-09 12:00 pm American Association for Cancer Research Meeting - Abstract No: 4195
2024-03-14 08:30 am Business Update Call
2024-03-05 12:50 pm TD Cowen Health Care Conference
2024-03-01 08:00 am Q4 2023 Earnings Release
2024-02-13 03:20 pm Oppenheimer Healthcare Life Sciences Conference
2024-02-07 01:00 pm Guggenheim Healthcare Talks Biotechnology Conference
2023-11-30 11:30 am Piper Sandler Healthcare Conference
2023-11-09 04:05 pm Q3 2023 Earnings Release
2023-10-12 12:30 pm AACR-NCI-EORTC International Conference - Abstract number: A093
2023-10-12 12:30 pm AACR-NCI-EORTC International Conference - Abstract number : A134
2023-09-13 10:10 am Morgan Stanley Global Healthcare Conference
2023-08-03 04:05 pm Q2 2023 Earnings Release
2023-06-14 11:00 am Annual General Meeting
2023-06-08 10:00 am Jefferies Global Healthcare Conference
2023-05-04 04:05 pm Q1 2023 Earnings Release
2023-04-19 12:45 pm Needham Healthcare Conference
2023-04-18 09:00 am American Association for Cancer Research Meeting - Abstract No 4265
2023-03-14 02:40 pm Oppenheimer Healthcare Conference
2023-03-07 04:45 pm American Association for Cancer Research Special conference - Abstract Number: B021

Annual results

Fiscal PeriodDecember 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


2,08
2,44
-14.91%
0,32
0,42
-24.74%
0,00
0,00
-

0,00

EBITDA
Million USD
Released
Forecast
Spread
0,00


-33,8
-34,0
0.61%
-51,5
-52,1
1.23%
-58,1
-58,2
0.17%

-72,1

EBIT
Million USD
Released
Forecast
Spread
0,00


-33,9
-32,4
-4.55%
-51,7
-53,2
2.77%
-58,4
-57,3
-1.92%

-75,8

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-33,8
-32,3
-4.7%
-50,5
-52,7
4.2%
-53,5
-52,5
-1.86%

-73,8

Net income
Million USD
Released
Forecast
Spread
-17,0


-33,5
-32,3
-3.75%
-50,5
-52,7
4.2%
-53,5
-52,5
-1.86%

-73,0

EPS
USD
Released
Forecast
Spread
-4,82


-2,46
-3,52
30.16%
-1,91
-2,00
4.26%
-1,88
-1,83
-2.52%

-1,85

Announcement Date13/05/2110/03/2206/03/2301/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
0,19
0,54
-64.6%
0,18
0,18
0.93%
0,09
0,18
-46.75%
0,04
0,15
-74.8%
0,00
0,05
-99.08%
0,00
0,01
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-11,1
-9,89
-12.42%
-12,9
-11,9
-8.65%
-11,6
-13,9
15.91%
-13,2
-13,2
0.11%
-14,0
-15,7
10.66%
-14,7
-14,8
0.68%
-13,5
-15,5
12.67%
-13,9
-15,0
7.09%
-16,3
-15,0
-8.45%

-17,5


-18,6


-20,1


-21,9


-23,3

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-11,1
-9,78
-13.37%
-12,9
-11,8
-9.4%
-11,5
-13,7
15.67%
-12,8
-13,1
1.84%
-13,2
-15,5
14.37%
-13,6
-14,5
6.03%
-12,2
-15,0
18.58%
-12,6
-14,3
11.79%
-15,1
-14,1
-6.88%

-16,7


-18,0


-19,7


-21,7


-22,1

Net income
Million USD
Released
Forecast
Spread
-10,8
-9,78
-10.23%
-12,9
-11,8
-9.4%
-11,5
-13,7
15.67%
-12,8
-13,1
1.84%
-13,2
-15,5
14.37%
-13,6
-14,5
6.03%
-12,2
-15,0
18.58%
-12,6
-14,3
11.79%
-15,1
-14,1
-6.88%

-16,6


-17,8


-19,3


-20,8


-22,1

EPS
USD
Released
Forecast
Spread
-0,05
-0,38
86.84%
-0,49
-0,45
-8.89%
-0,44
-0,52
15.38%
-0,49
-0,49
0%
-0,50
-0,58
14.04%
-0,51
-0,55
6.42%
-0,43
-0,51
16.39%
-0,43
-0,49
11.94%
-0,52
-0,46
-12.43%

-0,51


-0,49


-0,49


-0,43


-0,50

Announcement Date10/03/2210/05/2210/08/2210/11/2206/03/2304/05/2303/08/2309/11/2301/03/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. IMRX Stock
  4. Calendar Immuneering Corporation